Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Harnessing the Power of Aripiprazole for Autism Spectrum Disorder: Key Insights for Practitioners

Harnessing the Power of Aripiprazole for Autism Spectrum Disorder: Key Insights for Practitioners

As practitioners dedicated to improving outcomes for children with Autism Spectrum Disorder (ASD), staying informed about the latest research is crucial. One notable study, "Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis," provides valuable insights into the efficacy and safety of aripiprazole in treating behavioral disturbances in ASD. This blog will distill the key findings and suggest ways to incorporate this knowledge into practice.

Efficacy of Aripiprazole

The meta-analysis reviewed the efficacy, acceptability, and tolerability of aripiprazole in treating ASD-related symptoms. Key outcomes included:

Acceptability and Tolerability

Aripiprazole demonstrated higher overall acceptability and tolerability compared to placebo. Key points include:

Implications for Practice

Given these findings, practitioners can consider the following strategies:

Encouraging Further Research

While this meta-analysis provides robust evidence, the authors recommend further well-defined and large-sample studies to confirm these findings. Practitioners are encouraged to stay updated on emerging research and contribute to the body of knowledge through clinical observations and studies.

To read the original research paper, please follow this link: Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis.


Citation: Maneeton, N., Maneeton, B., Putthisri, S., Suttajit, S., Likhitsathian, S., & Srisurapanont, M. (2018). Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Neuropsychiatric Disease and Treatment, 14, 3063-3072. https://doi.org/10.2147/NDT.S174622
Marnee Brick, President, TinyEYE Therapy Services

Author's Note: Marnee Brick, TinyEYE President, and her team collaborate to create our blogs. They share their insights and expertise in the field of Speech-Language Pathology, Online Therapy Services and Academic Research.

Connect with Marnee on LinkedIn to stay updated on the latest in Speech-Language Pathology and Online Therapy Services.

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP